Background Pancreatic cancer is associated with an extremely poor prognosis, so new
biomarkers that can detect the initial stages are urgently needed. The significance of serum …

Objectives This study aimed to identify microRNAs as novel biomarkers for improved
diagnosis, prognosis prediction, and as a therapeutic target for pancreatic cancer …

Background: It is still uncertain whether small cell lung carcinomas (SCLCs), pulmonary
carcinoids, and the gastrointestinal neuroendocrine tumors (GI-NETs) have a common …

Pancreatic cancer (PC) has the poorest survival rate among all types of human cancer due
to the lack of sensitive and non-invasive diagnostic screen methods for PC screening. Our …

Pheochromocytoma (PCC) is a type of neuroendocrine tumor that originates from adrenal
medulla or extra-adrenal chromaffin cells and results in the production of catecholamine …

Background: Pancreatic cancer (PC) is a lethal disease, however current screening methods
unable to achieve early diagnosis. Blood-based microRNAs (miRNAs) are promising …

Specific, sensitive and non-invasive biomarkers are always needed in endocrine disorders.
miRNAs are short, non-coding RNA molecules with well-known role in gene expression …

Background: Primary tumor spread to the liver is the major cause of disease progression
and death in patients with colorectal cancer (CRC). MicroRNAs (miRNAs) are small non …

Pancreatic cancer represents one of the leading causes of oncological death worldwide. A
combination of pancreatic cancer aggressiveness and late diagnosis are key factors leading …

Background Clinical and pathologic markers of prognosis and patterns of failure help guide
clinicians in selecting patients for adjuvant therapy after surgical resection for pancreatic …